Who Paid My Doc
Omisirge
Biological Oncology
NDC 73441-800-04
General payments
$395,246
Research payments
$881,862
Through program year 2025, $395,246 in general payments and $881,862 in research payments were reported against Omisirge (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $169,248 | 152 |
| 2025 | Research | $170,019 | 12 |
| 2024 | General | $73,281 | 35 |
| 2024 | Research | $305,622 | 14 |
| 2023 | General | $152,717 | 21 |
| 2023 | Research | $406,221 | 25 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
208 general · 51 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.